Pandemics and ivermectin safety
US deaths more than 1918 pandemicUploaded 23-09-21Link to Wefwafwa’s channelhttps://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7owLink to todays featured videohttps://www.youtube.com/watch?v=XCKFBJRJcFATo donate to Wefwafwa’s workpatreon:https://www.patreon.com/awmedicalvideoshttps://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.htmlH1N1 virus with genes of avian originUnited States, first identified in military in spring 1918One-third of the world’s population became infectedGlobal deaths, at least 50 millionUS deaths, 675,000(CDC, 2021, 666,440)(JH, 2021, 681,199)https://coronavirus.jhu.edu/map.html(population, x 3 today)Pandemic subsides, but (H1N1) continues to circulate seasonally for 38 yearshttps://www.cdc.gov/flu/pandemic-resources/1918-commemoration/milestone-infographic.htmMortality in 1918 / 1919High in people younger than 5 years old20-40 years old, and 65 years and olderNo vaccine, no antibioticsUK in 1918https://www.historic-uk.com/HistoryUK/HistoryofBritain/The-Spanish-Flu-pandemic-of-1918/Deaths, 228,000(2021, 135,621 to 158,664)Global infection fatality rate, 10% to 20%Mr BidenExtra 500 million Pfizer doses for poorer countriesThe Food and Drug Administrationhttps://www.washingtonpost.com/health/2021/09/22/pfizer-booster-shot-fda-authorizes/Authorized a Pfizer booster, 65 and olderPeople 18 through 64, at high risk of severe illnessfrequent institutional or occupational exposureSix monthsIssuing emergency clearanceFDA commissioner Janet Woodcockhealth care workers, teachers and day care staff, grocery workers, homeless shelters or prisonsCenters for Disease Control and Prevention still must make precise recommendationsKey goal of boosters, prevention of serious disease, not prevention of mild infection? Pfizer booster for people who have been vaccinated with the Moderna or Johnson and JohnsonFewer side effects after third dose of mRNA vaccines compared with the second dosehttps://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-09-22/07-COVID-Talbot-508.pdfCOVID-19 Vaccine Safety Technical (VaST) Work Group Assessment of 3rd dose safety data H. Keipp Talbot, MD MPH (VaST Chair) Robert H. Hopkins, Jr., MD (NVAC Chair) Israel 3rd doses ,~2.8 M ≥12 yearsMost to persons ≥60 years Rates of reported systemic, local, neurologic, allergic, and other reactions were substantially lower after dose 3 than after dose 1 or 2 1,328 non serious19 serious adverse events, (7 possibly associated with vaccination) https://www.who-umc.org/vigibase/vigibase/http://www.vigiaccess.orgCorrectionhttps://www.hindustantimes.com/cities/lucknow-news/yogi-adityanath-launches-covid-19-medical-kits-for-covid-19-symptomatic-children-101623747649057.htmlState government, 50 lakh medical kits through village surveillance committees Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices